Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome

NCT00426543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Primary Sjögren's Syndrome
Xerostomia
Hyposalivation
Keratoconjunctivitis Sicca
Fatigue

Interventions

DRUG: MabThera (rituximab)
DRUG: Rituximab, Mabthera

Sponsor

University of Copenhagen

Collaborators

[object Object]